Imaging for target volume delineation in rectal cancer radiotherapy - a systematic review

Clinical Oncology

Volumn 24, Issue 1, 2012, Pages 52-63

  Gwynne, S ^a   Mukherjee, S ^b   Webster, R ^a   Spezi, E ^a   Staffurth, J ^c   Coles, B ^a   Adams, R ^c  

^a VELINDRE CANCER CENTRE   (United Kingdom)

^b UNIVERSITY OF OXFORD   (United Kingdom)

^c CARDIFF UNIVERSITY   (United Kingdom)

Author keywords

CT simulation; Interobserver variation; MR CT co registration; MRI planning; PET CT; Radiotherapy planning; Rectal cancer

Indexed keywords

1 FLUORO 3 (2 NITRO 1 IMIDAZOLYL) 2 PROPANOL; 3' FLUOROTHYMIDINE; ANTINEOPLASTIC AGENT; FLUORODEOXYGLUCOSE F 18;

ARTICLE; CANCER CHEMOTHERAPY; CANCER RADIOTHERAPY; COMPUTER ASSISTED EMISSION TOMOGRAPHY; COMPUTER ASSISTED TOMOGRAPHY; DIFFUSION WEIGHTED IMAGING; DOSIMETRY; HUMAN; IMAGE QUALITY; IMAGING; NUCLEAR MAGNETIC RESONANCE IMAGING; POSITRON EMISSION TOMOGRAPHY; PRIORITY JOURNAL; PROSTATE CANCER; RADIATION FIELD; RECTUM CANCER; SYSTEMATIC REVIEW; TREATMENT PLANNING;

DIAGNOSTIC IMAGING; HUMANS; PRACTICE GUIDELINES AS TOPIC; RADIOTHERAPY; RADIOTHERAPY PLANNING, COMPUTER-ASSISTED; RADIOTHERAPY, IMAGE-GUIDED; RECTAL NEOPLASMS;

EID: 84455192043     PISSN: 09366555     EISSN: 14332981     Source Type: Journal    
DOI: 10.1016/j.clon.2011.10.001     Document Type: Article

References (76)

1. Cancer Research UK. Latest UK cancer incidence and mortality summary. Available at: [accessed 21.02.11]. http://info.cancerresearchuk.org/prod_consump/groups/cr_common/%40nre/%4 0sta/documents/generalcontent/crukmig_1000ast-2735.pdf.
2. Diagnostic accuracy of preoperative magnetic resonance imaging in predicting curative resection of rectal cancer: prospective observational study. Br Med J 2006, 333:779. MERCURY Study Group.
3. Quirke P., Durdey P., Dixon M.F., Williams N.S. Local recurrence of rectal adenocarcinoma due to inadequate surgical resection. Histopathological study of lateral tumour spread and surgical excision. Lancet 1986, 2:996-999.
4. Heald R., MacFarlane J.K. Surgical management of rectal cancer. Br J Surg 1995, 82:1704-1705.
5. Carlsen E., Schlichting E., Guldvog I., Johnson E., Heald R. Effect of the introduction of total mesorectal excision for the treatment of rectal cancer. Br J Surg 1998, 85:526-529.
6. Cancer Research UK. Relative five-year survival estimates based on survival probabilities observed during 2000-2001, by sex and site, England and Wales. Available at: [accessed 21.02.11]. http://info.cancerresearchuk.org/prod_consump/groups/cr_common/%40nre/%4 0sta/documents/generalcontent/crukmig_1000ast-2774.xls.
7. Kapiteijn E., Marijnen C.A., Nagtegaal I.D., et al. Preoperative radiotherapy combined with total mesorectal excision for resectable rectal cancer. N Engl J Med 2001, 345:638-646.
8. Sebag-Montefiore D., Stephens R.J., Steele R., et al. Preoperative radiotherapy versus selective postoperative chemoradiotherapy in patients with rectal cancer (MRC CR07 and NCIC-CTG C016): a multicentre, randomised trial. Lancet 2009, 373:811-820.
9. Sauer R., Becker H., Hohenberger W., et al. Preoperative versus postoperative chemoradiotherapy for rectal cancer. N Engl J Med 2004, 351:1731-1740.
10. Bosset J., Collette L., Calais G., et al. Chemotherapy with preoperative radiotherapy in rectal cancer. N Engl J Med 2006, 355:1114-1123.
11. Wong R.K., Berry S., Spithoff K., et al. Preoperative or postoperative therapy for stage II or III rectal cancer: an updated practice guideline. Clin Oncol (R Coll Radiol) 2010, 22:265-271.
12. Roels S., Duthoy W., Haustermans K., et al. Definition and delineation of the clinical target volume for rectal cancer. Int J Radiat Oncol Biol Phys 2006, 65:1129-1142.
13. Syk E., Torkzad M.R., Blomqvist L., Nilsson P.J., Glimelius B. Local recurrence in rectal cancer: anatomic localization and effect on radiation target. Int J Radiat Oncol Biol Phys 2008, 72:658-664.
14. Nijkamp J., Kusters M., Beets-Tan R.G., et al. Three-dimensional analysis of recurrence patterns in rectal cancer: the cranial border in hypofractionated preoperative radiotherapy can be lowered. Int J Radiat Oncol Biol Phys 2011, 80:103-110.
15. Myerson R.J., Garofalo M.C., El Naqa I., et al. Elective clinical target volumes for conformal therapy in anorectal cancer: a radiation therapy oncology group consensus panel contouring atlas. Int J Radiat Oncol Biol Phys 2009, 74:824-830.
16. Tait D. Advances in chemoradiation therapy in rectal cancer: the impact of imaging. Br J Radiol 2005, 78(Spec no 2):S131-S137.
17. Cella L., Ciscognetti N., Martin G., et al. Preoperative radiation treatment for rectal cancer: comparison of target coverage and small bowel NTCP in conventional vs. 3D-conformal planning. Med Dosim 2009, 34:75-81.
18. Borger J., Bogaard J.V.D., Haas D.D., et al. Evaluation of three different CT simulation and planning procedures for the preoperative irradiation of operable rectal cancer. Radiother Oncol 2008, 87:350-356.
19. Martin N., Nawaz A., Schuller B., Kozak K., Hong T., Kachnic L. Dosimetric comparison of radiation techniques to the prone pelvis for rectal cancer: 3 field based on bony landmarks (2D) vs 3-dimensional conformal (3D) vs intensity modulated radiotherapy. Int J Radiat Oncol Biol Phys 2008, 72:S548.
20. Brown G., Davies S., Williams G., et al. Effectiveness of preoperative staging in rectal cancer: digital rectal examination, endoluminal ultrasound or magnetic resonance imaging?. Br JCancer 2004, 91:23-29.
21. Khoo V.S., Joon D.L. New developments in MRI for target volume delineation in radiotherapy. Br J Radiol 2006, 79(Spec. no 1):S2-S15.
22. Chao M., Gibbs P., Tjandra J., Darben P., Lim-Joon D., Jones I. Evaluation of the use of computed tomography versus conventional orthogonal X-ray simulation in the treatment of rectal cancer. Australas Radiol 2005, 49:122-126.
23. Corner C., Khimii F., Tsang Y.M., Harrison M., Jones R.G., Hughes R. Comparison of conventional and 3D conformal CT planning techniques for preoperative chemoradiotherapy for locally advanced rectal cancer. Int J Radiat Oncol Biol Phys 2008, 72:S547.
24. Yu S., Farmakidis D., Raouf S. Evaluation in acute toxicity in CT conformal versus simulator planned preoperative chemoradiotherapy in rectal carcinoma 2010, 12th World Congress on Gastrointestinal Cancer, ESMO, Barcelona.
25. Myerson R., Drzymala R. Technical aspects of image-based treatment planning of rectal carcinoma. Semin Radiat Oncol 2003, 13:433-440.
26. Khoo V. MRI-"Magic radiotherapy imaging" for treatment planning?. Br J Radiol 2000, 73:229-233.
27. Chen L., Price R.A., Nguyen T.B., et al. Dosimetric evaluation of MRI-based treatment planning for prostate cancer. Phys Med Biol 2004, 49:5157-5170.
28. The Royal College of Radiologists. Imaging for oncology. Available at: [accessed 09.05.11]. http://www.rcr.ac.uk/docs/oncology/pdf/BFCO(04)2_Imaging_Oncology.pdf.
29. Khoo V.S., Dearnaley D.P., Finnigan D.J., Padhani A., Tanner S.F., Leach M.O. Magnetic resonance imaging (MRI): considerations and applications in radiotherapy treatment planning. Radiother Oncol 1997, 42:1-15.
30. Dean C, Sykes J, Cooper R, etal. An evaluation of four CT-MRI co-registration techniques for radiotherapy treatment planning of prone rectal cancer patients. Br J Radiol, in press.
31. Brussel S.V., Deckers F., Laere S.V., et al. IMRT for rectal cancer patients based on diffusion weighted MRI (DWMRI). Int J Radiat Oncol Biol Phys 2008, 72:S251.
32. Sun Y.S., Zhang X.P., Tang L., et al. Locally advanced rectal carcinoma treated with preoperative chemotherapy and radiation therapy: preliminary analysis of diffusion-weighted MR imaging for early detection of tumor histopathologic downstaging. Radiology 2010, 254:170-178.
33. Anderson C., Koshy M., Staley C., et al. PET-CT fusion in radiation management of patients with anorectal tumors. Int JRadiat Oncol Biol Phys 2007, 69:155-162.
34. Ciernik I.F., Huser M., Burger C., Davis J.B., Szekely G. Automated functional image-guided radiation treatment planning for rectal cancer. Int J Radiat Oncol Biol Phys 2005, 62:893-900.
35. Gregoire V., Haustermans K., Geets X., Roels S., Lonneux M. PET-based treatment planning in radiotherapy: a new standard?. JNucl Med 2007, 48(Suppl. 1):68S-77S.
36. Nestle U., Kremp S., Schaefer-Schuler A., et al. Comparison of different methods for delineation of 18F-FDG PET-positive tissue for target volume definition in radiotherapy of patients with non-small cell lung cancer. J Nucl Med 2005, 46:1342-1348.
37. Brunetti J., Caggiano A., Rosenbluth B., Vialotti C. Technical aspects of positron emission tomography/computed tomography fusion planning. Semin Nucl Med 2008, 38:129-136.
38. MacManus M., Nestle U., Rosenzweig K.E., et al. Use of PET and PET/CT for radiation therapy planning: IAEA expert report 2006-2007. Radiother Oncol 2009, 91:85-94.
39. Schinagl D.A., Kaanders J.H., Oyen W.J. From anatomical to biological target volumes: the role of PET in radiation treatment planning. Cancer Imaging 2006, 6:S107-S116.
40. Steenbakkers R.J., Duppen J.C., Fitton I., et al. Reduction of observer variation using matched CT-PET for lung cancer delineation: a three-dimensional analysis. Int J Radiat Oncol Biol Phys 2006, 64:435-448.
41. Vees H., Senthamizhchelvan S., Miralbell R., Weber D.C., Ratib O., Zaidi H. Assessment of various strategies for 18F-FET PET-guided delineation of target volumes in high-grade glioma patients. Eur J Nucl Med Mol Imaging 2009, 36:182-193.
42. Black Q.C., Grills I.S., Kestin L.L., et al. Defining a radiotherapy target with positron emission tomography. Int J Radiat Oncol Biol Phys 2004, 60:1272-1282.
43. Ford E.C., Kinahan P.E., Hanlon L., et al. Tumor delineation using PET in head and neck cancers: threshold contouring and lesion volumes. Med Phys 2006, 33:4280-4288.
44. Erdi Y.E., Mawlawi O., Larson S.M., et al. Segmentation of lung lesion volume by adaptive positron emission tomography image thresholding. Cancer 1997, 80:2505-2509.
45. Davis J.B., Reiner B., Huser M., Burger C., Szekely G., Ciernik I.F. Assessment of 18F PET signals for automatic target volume definition in radiotherapy treatment planning. Radiother Oncol 2006, 80:43-50.
46. Biehl K.J., Kong F.M., Dehdashti F., et al. 18F-FDG PET definition of gross tumor volume for radiotherapy of non-small cell lung cancer: is a single standardized uptake value threshold approach appropriate?. J Nucl Med 2006, 47:1808-1812.
47. Li H., Thorstad W.L., Biehl K.J., et al. A novel PET tumor delineation method based on adaptive region-growing and dual-front active contours. Med Phys 2008, 35:3711-3721.
48. Geets X., Lee J.A., Bol A., Lonneux M., Gregoire V. A gradient-based method for segmenting FDG-PET images: methodology and validation. Eur J Nucl Med Mol Imaging 2007, 34:1427-1438.
49. Wanet M., Lee J.A., Weynand B., et al. Gradient-based delineation of the primary GTV on FDG-PET in non-small cell lung cancer: a comparison with threshold-based approaches, CT and surgical specimens. Radiother Oncol 2011, 98:117-125.
50. Yaremko B., Riauka T., Robinson D., et al. Thresholding in PET images of static and moving targets. Phys Med Biol 2005, 50:5969-5982.
51. Roels S., Slagmolen P., Nuyts J., et al. Biological image-guided radiotherapy in rectal cancer: is there a role for FMISO or FLT, next to FDG?. Acta Oncol 2008, 47:1237-1248.
52. Abrams R., Winter K., Regine W., et al. RTOG 9704-radiotherapy quality assurance (QA) review and survival. Int J Radiat Oncol Biol Phys 2006, 66:S22.
53. Peters L., O'Sullivan B., Giralt J., et al. Critical impact of radiotherapy protocol compliance and quality in the treatment of advanced head and neck cancer: results from TROG 02.02. J Clin Oncol 2010, 28:2996-3001.
54. Villeirs G.M., Van Vaerenbergh K., Vakaet L., et al. Interobserver delineation variation using CT versus combined CT+MRI in intensity-modulated radiotherapy for prostate cancer. Strahlenther Onkol 2005, 181:424-430.
55. Buijsen J., Bogaard J.V.D. PET-CT can reliably define the tumour dimensions of rectal cancer. Joint ECCO 15 - 34th ESMO Multidisciplinary Congress, 2009. Eur J Cancer 2009, 168-169. Suppl. 7.
56. Yavuz M, Pehlivan B, Aydin M, etal. Comparison of CT-guided and PET-CT guided radiotherapy planning in patients with rectum cancer treated preoperatively. Joint ECCO 15 - 34th ESMO Multidisciplinary Congress, 2009. Conference Publication 7: 329.
57. Betler J., Day E., Kirichenko A., et al. Evaluation of FDG-PET/CT imaging in treatment planning for distal rectal (DR) and anal canal (AC) carcinomas. Int J Radiat Oncol Biol Phys 2008, 72:S258.
58. Oxford Centre of Evidence Based Medicine. Levels of evidence. Available at: [accessed 09.05.11]. http://www.cebm.net/index.aspx%3Fo%3D1025.
59. Krengli M., Cannillo B., Turri L., et al. Target volume delineation for preoperative radiotherapy or rectal cancer: inter-observer variability and potential impact of FDG-PET/CT imaging. Technol Cancer Res Treat 2010, 9:393-398.
60. O'Neill B.D., Salerno G., Thomas K., Tait D.M., Brown G. MR vs CT imaging: low rectal cancer tumour delineation for three-dimensional conformal radiotherapy. Br J Radiol 2009, 82:509-513.
61. Tan J., Lim Joon D., Fitt G., et al. The utility of multimodality imaging with CT and MRI in defining rectal tumour volumes for radiotherapy treatment planning: a pilot study. J Med Imaging Radiat Oncol 2010, 54:562-568.
62. Seierstad T., Hole K.H., Saelen E., Ree A.H., Flatmark K., Malinen E. MR-guided simultaneous integrated boost in preoperative radiotherapy of locally advanced rectal cancer following neoadjuvant chemotherapy. Radiother Oncol 2009, 93:279-284.
63. Patel D., Chang S., Goodman K., et al. Impact of integrated PET/CT on variability of target volume delineation in rectal cancer. Technol Cancer Res Treat 2007, 6:31-35.
64. Bassi M., Turri L., Sacchetti G., et al. FDG-PET/CT imaging for staging and target volume delineation in preoperative conformal radiotherapy of rectal cancer. Int J Radiat Oncol Biol Phys 2008, 70:1423-1426.
65. Paskeviciute B., Bolling T., Brinkmann M., et al. Impact of FDG-PET/CT on staging and irradiation of patients with locally advanced rectal cancer. Strahlenther Onkol 2009, 185:260-265.
66. Day E., Betler J., Parda D., Mohammadi S., Miften M. A region growing method for tumor volume segmentation on PET images for rectal and anal cancer patients. Med Phys 2009, 36:4349-4358.
67. Fuller C.D., Nijkamp J., Duppen J.C., et al. Prospective randomized double-blind pilot study of site-specific consensus atlas implementation for rectal cancer target volume delineation in the cooperative group setting. Int J Radiat Oncol Biol Phys 2011, 79:481-489.
68. Vorwerk H., Liersch T., Rothe H., et al. Gold markers for tumor localization and target volume delineation in radiotherapy for rectal cancer. Strahlenther Onkol 2009, 185:127-133.
69. Myerson R, Garofalo M, Naqa I, etal. Elective clinical target volumes in anorectal cancer: an RTOG consensus panel contouring atlas. Available at: [accessed 24.02.11]. http://www.rtog.org/pdf_file2.html%3Fpdf_document%3DAnorectalContouringG uidelines.pdf.
70. NCRI. A framework for PET research in the UK: Report of the NCRI PET strategic planning group. Available at: [accessed 24.02.11]. http://www.ncri.org.uk/includes/What_We_Do/researchnetworks/documents/NC RIFrameworkforPETResearch2007_000.pdf.
71. Khoo V.S., Padhani A.R., Tanner S.F., Finnigan D.J., Leach M.O., Dearnaley D.P. Comparison of MRI with CT for the radiotherapy planning of prostate cancer: a feasibility study. Br J Radiol 1999, 72:590-597.
72. Boellaard R., O'Doherty M.J., Weber W.A., et al. FDG PET and PET/CT: EANM procedure guidelines for tumour PET imaging: version 1.0. Eur J Nucl Med Mol Imaging 2010, 37:181-200.
73. Chen L., Paskalev K., Xu X., et al. Rectal dose variation during the course of image-guided radiation therapy of prostate cancer. Radiother Oncol 2010, 95:198-202.
74. Ma D.J., Zhu J.M., Grigsby P.W. Tumor volume discrepancies between FDG-PET and MRI for cervical cancer. Radiother Oncol 2011, 98:139-142.
75. Gwynne S., Webster R., Mukherjee S., Staffurth J., Spezi E., Adams R. Image-guided radiotherapy for rectal cancer - a systematic review. Clin Oncol (R Coll Radiol) 2011, 10.1016/j.clon.2011.07.012.
76. Yavuz M.N., Topkan E., Yavuz A.A., et al. FDG-PET/CT imaging-based target volume delineation for preoperative conformal radiotherapy of rectal carcinoma. Int J Haem Oncol 2010, 20:67-74.